Real-world Clinical Outcomes in a U.S. Asian Population with Stage IV NSCLC Treated with Osimertinib (osi) Stratified by EGFR Subtype.
JOURNAL OF CLINICAL ONCOLOGY(2023)
Key words
osimertinib,stage IV lung cancer,Non small cell lung cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined